Search by Drug Name or NDC

NDC 43063-0407-14 ORPHENADRINE CITRATE 100 mg/1 Details

ORPHENADRINE CITRATE 100 mg/1

ORPHENADRINE CITRATE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is ORPHENADRINE CITRATE.

MedlinePlus Drug Summary

Orphenadrine is used with rest, physical therapy, and other measures to relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Orphenadrine is in a class of medications called skeletal muscle relaxants. It works by changing the way the body senses muscle pain.

Related Packages: 43063-0407-14
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Orphenadrine

Product Information

NDC	43063-0407
Product ID	43063-407_f93c91b7-5392-c4ea-e053-6394a90ac0c9
Associated GPIs	75100080107410
GCN Sequence Number	004595
GCN Sequence Number Description	orphenadrine citrate TABLET ER 100 MG ORAL
HIC3	H6H
HIC3 Description	SKELETAL MUSCLE RELAXANTS
GCN	17670
HICL Sequence Number	001906
HICL Sequence Number Description	ORPHENADRINE CITRATE
Brand/Generic	Generic
Proprietary Name	ORPHENADRINE CITRATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	ORPHENADRINE CITRATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	ORPHENADRINE CITRATE
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA040284
Listing Certified Through	2024-12-31

Package

NDC 43063-0407-14 (43063040714)

Pricing Information	N/A
NDC Package Code	43063-407-14
Billing NDC	43063040714
Package	14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-407-14)
Marketing Start Date	2013-06-18
NDC Exclude Flag	N